Author: OurCrowd

Newsletter: 5 reasons a startup might snap up its neighbor

Top investment opportunitiesStartup of the Week: Merck’s VC arm takes lead in Genopore investment5 reasons a startup might snap up its neighborWhat does Netanyahu’s return mean for Israeli high tech?Nov. 9 Online: Labs/02 Startup Demo Day IIOurCrowd hosts Italian delegation led by Intesa Sanpaolo GroupDataloop raises $33M Series BWWD: ByondXR pioneers course at Fashion Institute of TechnologyOnsemi picks Ride Vision for motorcycle safety featuresWefox CEO on CNBC: Huge opportunity in $5.2T pre-digital insurance industryMore than 4,500 high-tech jobs Startup of the WeekMerck’s VC arm takes lead in Genopore investment Photo: http://www.meller-lab.net M Ventures, the VC arm of Merck KGaA, Darmstadt, Germany, has come in to lead Genopore’s seed round. Genopore aims to revolutionize early disease detection through proteomics, the extensive study of proteins. Its groundbreaking testing capability for proteomics will provide the equivalent of DNA sequencing for proteins, allowing medical professionals to identify cancer and other serious conditions in initial stages. Genopore plans to be the first company to deliver a high-throughput, single-molecule, whole-protein identification system using chip-based technology that is cost effective, accurate and highly sensitive. OurCrowd is investing...

Read More